Hypoxia-induced angiogenesis in human hepatocellular carcinoma.
about
Negative regulation of hypoxia inducible factor-1alpha by necdinCranial arterial patterns of the alpaca (Camelidae: Vicugna pacos).Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumorsTargeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply.Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration.Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition.Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissuesIncreased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization.Hepatic arterial administration of ginsenoside Rg3 and transcatheter arterial embolization for the treatment of VX2 liver carcinomas.Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma.Assessment of blood flow in hepatocellular carcinoma: correlations of computed tomography perfusion imaging and circulating angiogenic factorsN-myc downstream-regulated gene 1: Diverse and complicated functions in human hepatocellular carcinoma (Review)PKIB promotes cell proliferation and the invasion-metastasis cascade through the PI3K/Akt pathway in NSCLC cellsHypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model.The role of CK7, Ki-67, CD34 and vimentin in the differentiation between biliary atresia and idiopathic neonatal hepatitis in Egyptian cholestatic neonates.Hepatocellular carcinoma targeting agents: conjugates of nitroimidazoles with trimethyl nordihydroguaiaretic acid.Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma.The integrin-linked kinase gene up-regulated by hypoxia plays its pro-survival role in colorectal cancer cells.Molecular mechanisms of sorafenib action in liver cancer cells.Coexpression of hypoxia-inducible factor-2α, TWIST2, and SIP1 may correlate with invasion and metastasis of salivary adenoid cystic carcinoma.Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma.Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model.Safety and efficacy of adjuvant pegylated interferon therapy for metastatic tumor antigen 1-positive hepatocellular carcinoma.Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway.Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-κB/hypoxia-inducible factor-1α axis under hypoxic conditions.Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.Modulation of HIF-1α and STAT3 signaling contributes to anti-angiogenic effect of YC-1 in mice with liver fibrosis.Metastasis associated protein 1 correlates with Hypoxia inducible-factor 1 alpha expression and lymphangiogenesis in esophageal cancer.Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma.Chronic Hypoxia Emerging as One of the Driving Forces behind Gene Expression and Prognosis of Hepatocellular Carcinoma
P2860
Q28258299-C86E67B8-95C6-4A08-AED9-6BACB3C3D9E1Q30358854-865749C1-C8BF-46DD-A62F-CB36B9A19DD9Q30932207-7EE533B7-9C51-405F-BD01-E469C0B49374Q33376925-8CFA522E-191D-4A66-AE56-8F72040475BAQ33920350-C3C3AF3E-6EC7-4C28-8816-82DE5CAD9AB1Q34130424-B135CD84-B3B3-4170-9AEF-16A0A0424030Q34225706-9DC6DF80-28E8-40F5-9BB7-C6501615236DQ34605633-43E331CA-AFA9-4725-ADE8-0F02A62B05B2Q35600929-DFD94539-8407-4234-BB35-C3865DC87926Q36603569-3A60CAC7-C73A-4176-AC18-3557427CCA05Q36675088-7250BAF7-FC8C-4848-BB3B-F583D88AB536Q36746133-DC7ACB68-E1E7-491E-9FE9-B8DD3A76B70DQ36772115-3ED15AF4-68A6-408D-94E8-9ECF8A6F22A3Q36845140-083F331C-90A7-499C-BEEA-A77B72A245DCQ37225055-09387951-F91B-4AA0-9645-280798689497Q37326766-65C45FA6-6D6F-42E8-92F5-4D41E4975E25Q37347199-1D1E5E94-6B6A-45A5-B2B3-8D994F787285Q37688142-CC51A947-62F8-45F8-BE2B-0E9548DF14D4Q37704703-C4E8C0A0-4AD6-4D0D-80BF-8FD8528D8187Q38864182-F72A03DC-3B5D-4536-8F54-B91E599A2948Q39013727-5FF474A8-2262-4F46-B46A-D8659170ACBEQ39018915-0528CC3E-EA32-43C4-80B0-5FE36BD18D5CQ39050488-1FAE6352-22A9-4744-BA3B-7E3AD35DCD30Q39313526-40C95100-B122-4702-8FE2-CEAF7B0AB176Q39439422-57004CFD-F36C-4E54-BC76-E9601357BD66Q40168010-7F10881A-19F2-4129-ACF8-727F51359B8FQ40252978-2368C650-37CE-46FB-984F-6800CD572E24Q44365724-424EF561-EA2B-46EE-A010-A1FFC15753D0Q44950247-3C8B7B12-6256-4820-BD69-A4535511815FQ45360614-755A7DD5-3D0A-4F7B-B0A6-576D6471EB7EQ46635717-051D7E33-AC63-498D-9BEC-6F29DBE40E65Q47122258-9B897F77-CC04-46CC-8639-E3A80E07659FQ47896398-C5414FE8-D5B6-48DD-B412-5DA9EC365C71Q48018285-C437B8D6-0D22-40F5-B5EE-C85B6BC56C54Q53548617-ACB99F85-74F6-4893-8906-F7A195957C11Q58689162-2E8A4391-B1C8-425A-A367-6AB1E4F09AD7
P2860
Hypoxia-induced angiogenesis in human hepatocellular carcinoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hypoxia-induced angiogenesis in human hepatocellular carcinoma.
@ast
Hypoxia-induced angiogenesis in human hepatocellular carcinoma.
@en
type
label
Hypoxia-induced angiogenesis in human hepatocellular carcinoma.
@ast
Hypoxia-induced angiogenesis in human hepatocellular carcinoma.
@en
prefLabel
Hypoxia-induced angiogenesis in human hepatocellular carcinoma.
@ast
Hypoxia-induced angiogenesis in human hepatocellular carcinoma.
@en
P2093
P1476
Hypoxia-induced angiogenesis in human hepatocellular carcinoma.
@en
P2093
Hyo-Eun Moon
Kwang-Rok Kim
Kyu-Won Kim
P2888
P304
P356
10.1007/S00109-002-0380-0
P577
2002-09-17T00:00:00Z